Home
CVAC
CVAC News

Latest CureVac N.V. (CVAC) News on July 26, 2024

CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

11 days ago

CureVac (CVAC) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

15 days ago

CureVac Provides Trial Dates for Patent Litigation Against Pfizer, BioNTech

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

ACCESSWIRE

16 days ago

CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech

An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued

Simply Wall St.

21 days ago

An Intrinsic Calculation For CureVac N.V. (NASDAQ:CVAC) Suggests It's 47% Undervalued

Morningstar Research

22 days ago

Analyst Report: CureVac N.V.

GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac

Zacks

22 days ago

GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac

Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More

Zacks

22 days ago

Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More

CureVac announces restructuring to focus on mRNA projects

Pharmaceutical Technology

23 days ago

CureVac announces restructuring to focus on mRNA projects

MT Newswires

23 days ago

Sector Update: Health Care Stocks Fall in Afternoon Trading

GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines

Investopedia

23 days ago

GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines

MT Newswires

23 days ago

Sector Update: Health Care

GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines

Barrons.com

23 days ago

GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines

Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine

Zacks

23 days ago

Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine

MT Newswires

23 days ago

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires

23 days ago

Sector Update: Health Care

GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion

MT Newswires

23 days ago

GSK to Buy COVID-19, Flu Vaccine Rights From CureVac for $1.56 Billion

CureVac cuts jobs, licenses out vaccines to GSK

BioPharma Dive

23 days ago

CureVac cuts jobs, licenses out vaccines to GSK

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion

The Wall Street Journal

24 days ago

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion

GSK and CureVac restructure mRNA vaccine development deal

Pharmaceutical Technology

24 days ago

GSK and CureVac restructure mRNA vaccine development deal

MT Newswires

24 days ago

CureVac Enters Into New Licensing Agreement With GSK; to Implement 'Significant' Restructuring; Shares Rise Pre-Bell

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

ACCESSWIRE

24 days ago

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

ACCESSWIRE

24 days ago

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

GSK buys COVID, influenza vaccines from retrenching CureVac

Reuters

24 days ago

GSK buys COVID, influenza vaccines from retrenching CureVac

CureVac Announces Voting Results of General Meeting

ACCESSWIRE

a month ago

CureVac Announces Voting Results of General Meeting

Morningstar Research

a month ago

Analyst Report: CureVac N.V.

Morningstar Research

2 months ago

Analyst Report: CureVac N.V.

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK

ACCESSWIRE

2 months ago

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK

CureVac N.V. (NASDAQ:CVAC) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Simply Wall St.

2 months ago

CureVac N.V. (NASDAQ:CVAC) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

CureVac First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

2 months ago

CureVac First Quarter 2024 Earnings: Misses Expectations

Morningstar Research

2 months ago

Analyst Report: CureVac N.V.

Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks

The Wall Street Journal

2 months ago

Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks

Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

Zacks

2 months ago

Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

ACCESSWIRE

2 months ago

CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update

Some Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) Estimates

Simply Wall St.

3 months ago

Some Analysts Just Cut Their CureVac N.V. (NASDAQ:CVAC) Estimates

CureVac Full Year 2023 Earnings: Misses Expectations

Simply Wall St.

3 months ago

CureVac Full Year 2023 Earnings: Misses Expectations

CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript

Insider Monkey

3 months ago

CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript

Morningstar Research

3 months ago

Analyst Report: CureVac N.V.

MT Newswires

3 months ago

CureVac Begins Early Stage Portion of Investigational Vaccine Trial

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

ACCESSWIRE

3 months ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK

ACCESSWIRE

3 months ago

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

ACCESSWIRE

3 months ago

CureVac Appoints Thaminda Ramanayake as New Chief Business Officer

CureVac to cut costs in restructuring

BioPharma Dive

3 months ago

CureVac to cut costs in restructuring

CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%

Simply Wall St.

3 months ago

CureVac N.V. (NASDAQ:CVAC) stock most popular amongst private equity firms who own 31%, while individual investors hold 30%

CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024

ACCESSWIRE

3 months ago

CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024

CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines

ACCESSWIRE

3 months ago

CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines

CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK

ACCESSWIRE

4 months ago

CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK

Morningstar Research

5 months ago

Analyst Report: CureVac N.V.

Redfin to Announce Fourth-Quarter 2023 Results on February 27, 2024

Business Wire

6 months ago

Redfin to Announce Fourth-Quarter 2023 Results on February 27, 2024

Here's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation

Simply Wall St.

6 months ago

Here's Why We're Watching CureVac's (NASDAQ:CVAC) Cash Burn Situation

Aspen Aerogels to Present at Wolfe Research's Global Auto and Auto Tech Conference

PR Newswire

6 months ago

Aspen Aerogels to Present at Wolfe Research's Global Auto and Auto Tech Conference

Look Beyond Profit, Bet on 4 Stocks With Increasing Cash Flows

Zacks

6 months ago

Look Beyond Profit, Bet on 4 Stocks With Increasing Cash Flows

15 Best Places in Louisiana for a Couple to Live on Only Social Security

Insider Monkey

6 months ago

15 Best Places in Louisiana for a Couple to Live on Only Social Security

Brookline Bancorp, Inc. (NASDAQ:BRKL) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Brookline Bancorp, Inc. (NASDAQ:BRKL) Q4 2023 Earnings Call Transcript

18 Best 52-Week Low Stocks To Buy Now

Insider Monkey

6 months ago

18 Best 52-Week Low Stocks To Buy Now

Armour Residential REIT (ARR) Flat As Market Sinks: What You Should Know

Zacks

6 months ago

Armour Residential REIT (ARR) Flat As Market Sinks: What You Should Know

20 States Where You May Not Be Able to Retire at Age 65

Insider Monkey

6 months ago

20 States Where You May Not Be Able to Retire at Age 65

Down -14.25% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

Zacks

6 months ago

Down -14.25% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

The Fed Tells Banks Not to Be Shy About Asking It for Money

Bloomberg

6 months ago

The Fed Tells Banks Not to Be Shy About Asking It for Money

With 54% ownership, ARMOUR Residential REIT, Inc. (NYSE:ARR) boasts of strong institutional backing

Simply Wall St.

6 months ago

With 54% ownership, ARMOUR Residential REIT, Inc. (NYSE:ARR) boasts of strong institutional backing

Steward Health Taps Restructuring Advisers Following Worsening Financials

The Wall Street Journal

6 months ago

Steward Health Taps Restructuring Advisers Following Worsening Financials

GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL

GlobeNewswire

6 months ago

GRAY SETS DATE FOR FOURTH QUARTER EARNINGS RELEASE AND EARNINGS CONFERENCE CALL

Armada Hoffler’s BBB Credit Rating Confirmed by Morningstar DBRS

GlobeNewswire

6 months ago

Armada Hoffler’s BBB Credit Rating Confirmed by Morningstar DBRS

Barings BDC, Inc. Reports Preliminary Fourth Quarter 2023 Results

Business Wire

6 months ago

Barings BDC, Inc. Reports Preliminary Fourth Quarter 2023 Results

Down -15.09% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

Zacks

6 months ago

Down -15.09% in 4 Weeks, Here's Why You Should You Buy the Dip in CureVac N.V. (CVAC)

PartsToGo Scales Additive Manufacturing Capabilities with Addition of Stratasys SLA Solutions

Business Wire

6 months ago

PartsToGo Scales Additive Manufacturing Capabilities with Addition of Stratasys SLA Solutions

Q4 Earnings Roundup: Kura Sushi (NASDAQ:KRUS) And The Rest Of The Sit-Down Dining Segment

StockStory

6 months ago

Q4 Earnings Roundup: Kura Sushi (NASDAQ:KRUS) And The Rest Of The Sit-Down Dining Segment

Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq

PR Newswire

6 months ago

Churchill Capital Corp VII Announces Intention to Transfer Listing to Nasdaq

Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

PR Newswire

6 months ago

Aspen Aerogels, Inc. Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

Should You Think About Buying Gray Television, Inc. (NYSE:GTN) Now?

Simply Wall St.

6 months ago

Should You Think About Buying Gray Television, Inc. (NYSE:GTN) Now?

CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update

PR Newswire

6 months ago

CorpAcq Reaffirms 2023 Guidance and Provides Business and Refinancing Update

Strength Seen in NovoCure (NVCR): Can Its 16.8% Jump Turn into More Strength?

Zacks

6 months ago

Strength Seen in NovoCure (NVCR): Can Its 16.8% Jump Turn into More Strength?

F.N.B. (FNB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

6 months ago

F.N.B. (FNB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why

Zacks

6 months ago

Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why

Perion Network to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

Business Wire

6 months ago

Perion Network to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

Six Flags Launches Largest Digital Alliance in Theme Park Industry

Business Wire

6 months ago

Six Flags Launches Largest Digital Alliance in Theme Park Industry

CTS Corporation to Participate in the Needham Growth Conference

GlobeNewswire

6 months ago

CTS Corporation to Participate in the Needham Growth Conference

3 Small-Cap Semiconductor Stocks on Fast Track to Double in 2024

InvestorPlace

6 months ago

3 Small-Cap Semiconductor Stocks on Fast Track to Double in 2024

TDCX Inc. Special Committee Engages Financial Advisor and Legal Counsels

Business Wire

6 months ago

TDCX Inc. Special Committee Engages Financial Advisor and Legal Counsels

Ecovyst Names Kara L. Thornton Vice President and Chief Human Resources Officer

PR Newswire

6 months ago

Ecovyst Names Kara L. Thornton Vice President and Chief Human Resources Officer

Agiliti Inc CEO Thomas Leonard Sells 27,558 Shares

GuruFocus.com

6 months ago

Agiliti Inc CEO Thomas Leonard Sells 27,558 Shares

Optimism for TechTarget (NASDAQ:TTGT) has grown this past week, despite five-year decline in earnings

Simply Wall St.

6 months ago

Optimism for TechTarget (NASDAQ:TTGT) has grown this past week, despite five-year decline in earnings

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

GlobeNewswire

7 months ago

Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results

3 REITs to Sell in January Before They Crash and Burn

InvestorPlace

7 months ago

3 REITs to Sell in January Before They Crash and Burn

Amphastar Pharmaceuticals (AMPH) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

7 months ago

Amphastar Pharmaceuticals (AMPH) Stock Drops Despite Market Gains: Important Facts to Note

Lindsay (LNN) Q1 Earnings Beat Estimates, Revenues Miss

Zacks

7 months ago

Lindsay (LNN) Q1 Earnings Beat Estimates, Revenues Miss

CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform

ACCESSWIRE

7 months ago

CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform

Wabash Schedules Fourth Quarter 2023 Earnings Conference Call

GlobeNewswire

7 months ago

Wabash Schedules Fourth Quarter 2023 Earnings Conference Call

3 Dividend Stocks for Strong Returns in 2024 and Beyond

InvestorPlace

7 months ago

3 Dividend Stocks for Strong Returns in 2024 and Beyond

CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

7 months ago

CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

TDCX Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Remaining Outstanding Class A Ordinary Shares of the Company

Business Wire

7 months ago

TDCX Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Remaining Outstanding Class A Ordinary Shares of the Company

Columbus McKinnon Announces Kristine Moser as Vice President, Investor Relations and Treasurer

Business Wire

7 months ago

Columbus McKinnon Announces Kristine Moser as Vice President, Investor Relations and Treasurer

The Zacks Analyst Blog Highlights CrowdStrike, PagerDuty, PLDT, Atmos Energy and Granite Construction

Zacks

7 months ago

The Zacks Analyst Blog Highlights CrowdStrike, PagerDuty, PLDT, Atmos Energy and Granite Construction

A Look At The Intrinsic Value Of BeiGene, Ltd. (NASDAQ:BGNE)

Simply Wall St.

7 months ago

A Look At The Intrinsic Value Of BeiGene, Ltd. (NASDAQ:BGNE)

Could Nano Dimension Stock Print New Millionaire Investors in 2024?

Motley Fool

7 months ago

Could Nano Dimension Stock Print New Millionaire Investors in 2024?

13 Best Get Rich Quick Stocks To Buy

Insider Monkey

7 months ago

13 Best Get Rich Quick Stocks To Buy

Corcept loses patent spat against Teva, shares tumble

Reuters

7 months ago

Corcept loses patent spat against Teva, shares tumble

ProFrac Holding Corp. Completes Refinancing of Senior Secured Term Loan and Enhances Financial Flexibility

PR Newswire

7 months ago

ProFrac Holding Corp. Completes Refinancing of Senior Secured Term Loan and Enhances Financial Flexibility

Star Bulk Carriers (SBLK) Exceeds Market Returns: Some Facts to Consider

Zacks

7 months ago

Star Bulk Carriers (SBLK) Exceeds Market Returns: Some Facts to Consider

These Analysts Just Made A Huge Downgrade To Their CureVac N.V. (NASDAQ:CVAC) EPS Forecasts

Simply Wall St.

7 months ago

These Analysts Just Made A Huge Downgrade To Their CureVac N.V. (NASDAQ:CVAC) EPS Forecasts

Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?

Benzinga

7 months ago

Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?

Share on Social Networks: